3d0g
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<StructureSection load='3d0g' size='340' side='right' caption='[[3d0g]], [[Resolution|resolution]] 2.80Å' scene=''> | <StructureSection load='3d0g' size='340' side='right' caption='[[3d0g]], [[Resolution|resolution]] 2.80Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[3d0g]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3D0G OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3D0G FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[3d0g]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Cvhsa Cvhsa] and [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3D0G OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3D0G FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=NDG:2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE'>NDG</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=NDG:2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE'>NDG</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2ajf|2ajf]], [[3d0h|3d0h]], [[3d0i|3d0i]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2ajf|2ajf]], [[3d0h|3d0h]], [[3d0i|3d0i]]</td></tr> | ||
+ | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">ACE2, UNQ868/PRO1885 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN]), S, 2 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=227859 CVHSA])</td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Angiotensin-converting_enzyme_2 Angiotensin-converting enzyme 2], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.17.23 3.4.17.23] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Angiotensin-converting_enzyme_2 Angiotensin-converting enzyme 2], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.17.23 3.4.17.23] </span></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3d0g FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3d0g OCA], [http://pdbe.org/3d0g PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3d0g RCSB], [http://www.ebi.ac.uk/pdbsum/3d0g PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3d0g ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3d0g FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3d0g OCA], [http://pdbe.org/3d0g PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3d0g RCSB], [http://www.ebi.ac.uk/pdbsum/3d0g PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3d0g ProSAT]</span></td></tr> | ||
Line 30: | Line 31: | ||
</div> | </div> | ||
<div class="pdbe-citations 3d0g" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 3d0g" style="background-color:#fffaf0;"></div> | ||
- | |||
- | ==See Also== | ||
- | *[[Angiotensin-Converting Enzyme|Angiotensin-Converting Enzyme]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
Line 38: | Line 36: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Angiotensin-converting enzyme 2]] | [[Category: Angiotensin-converting enzyme 2]] | ||
+ | [[Category: Cvhsa]] | ||
+ | [[Category: Human]] | ||
[[Category: Li, F]] | [[Category: Li, F]] | ||
[[Category: Ace2]] | [[Category: Ace2]] | ||
Line 47: | Line 47: | ||
[[Category: Host adaptation]] | [[Category: Host adaptation]] | ||
[[Category: Host-virus interaction]] | [[Category: Host-virus interaction]] | ||
- | [[Category: Human]] | ||
[[Category: Hydrolase]] | [[Category: Hydrolase]] | ||
[[Category: Lipoprotein]] | [[Category: Lipoprotein]] |
Revision as of 08:39, 25 October 2017
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus human strain complexed with human-civet chimeric receptor ACE2
|
Categories: Angiotensin-converting enzyme 2 | Cvhsa | Human | Li, F | Ace2 | Carboxypeptidase | Chloride | Cross-species infection | Envelope protein | Glycoprotein | Host adaptation | Host-virus interaction | Hydrolase | Lipoprotein | Membrane | Metal-binding | Metalloprotease | Palm civet | Palmitate | Protease | Rbd | Receptor-binding domain | Sars coronavirus | Secreted | Spike protein | Transmembrane | Virion | Virulence | Virus-host interface